Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Alphatec | ATEC | Jan 16, 2025 | 11.29 | -0.53 |
AlphaTime Acquisition | ATMC | Jan 16, 2025 | 11.32 | 0.00 |
AlphaVest Acquisition | ATMV | Jan 16, 2025 | 11.37 | 0.00 |
AlphaVest Acquisition Unit | ATMVU | Jan 16, 2025 | 11.31 | 0.00 |
Alpine Income Property | PINE | Jan 16, 2025 | 17.02 | +1.37 |
Alps Alerian MLP ETF | AMLP | Jan 16, 2025 | 51.48 | +1.36 |
Alps Equal Sector Weight ETF | EQL | Jan 16, 2025 | 128.06 | +0.65 |
Alps International Sector Divid | IDOG | Jan 16, 2025 | 29.13 | -0.13 |
Alps Sector Dividend Dogs ETF | SDOG | Jan 16, 2025 | 57.40 | +0.46 |
Alset EHome International | AEI | Jan 16, 2025 | 0.85 | -3.43 |
Alt5 Sigma | ALTS | Jan 16, 2025 | 5.96 | -2.13 |
Alta Equipment A Pref | ALTG-A | Jan 16, 2025 | 25.63 | +0.26 |
Alta Equipment Group A | ALTG | Jan 16, 2025 | 7.21 | -0.14 |
Altair Engineering A | ALTR | Jan 16, 2025 | 110.12 | -0.10 |
AltEnergy Acquisition A | AEAE | Jan 16, 2025 | 11.22 | 0.00 |
AltEnergy Acquisition Unit | AEAEU | Jan 16, 2025 | 11.30 | 0.00 |
Alterity Therapeutics ADR | ATHE | Jan 16, 2025 | 3.36 | +1.42 |
Alternus Clean Energy A | ALCE | Jan 16, 2025 | 0.53 | +0.38 |
Alti Global A | ALTI | Jan 16, 2025 | 4.01 | -3.14 |
Altice USA A | ATUS | Jan 16, 2025 | 2.73 | +2.63 |
Altimmune | ALT | Jan 16, 2025 | 6.71 | +1.98 |
Altisource Portfolio Solutions | ASPS | Jan 16, 2025 | 0.66 | -3.78 |
Alto Ingredients | ALTO | Jan 16, 2025 | 1.81 | +9.70 |
Alto Neuroscience | ANRO | Jan 16, 2025 | 4.43 | +3.02 |
Altria Group | MO | Jan 16, 2025 | 51.16 | +0.24 |
Altus Power A | AMPS | Jan 16, 2025 | 3.80 | -1.04 |
Alumis | ALMS | Jan 16, 2025 | 7.79 | +0.78 |
Alvotech | ALVO | Jan 16, 2025 | 13.23 | +0.23 |
ALX Oncology | ALXO | Jan 16, 2025 | 1.63 | 0.00 |
Alzamend Neuro | ALZN | Jan 16, 2025 | 1.15 | -1.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.